AI explained. Tools tested. Ideas worth trying.By Sam Taylor & Samwise ↗

Topic · Archive

Research stories.
Every angle.

016

Stories synthesized

arXiv papers with social-media velocity, Hugging Face daily-papers top picks, and research cited by Tier-1 sources. The synthesis here focuses on the single counter-intuitive finding, honest limitations, and the question builders actually care about: does this affect production decisions today, or is it 12 months out?

BuilderResearch

Claude may have found biology's next big editing tool. The method — 950 agents, 21 hours — is the actual story.

Anthropic's life sciences group announced September 23 that 950+ Claude agents spent 21 hours searching a massive DNA sequence database and found a novel enzyme system in bacteriophages with CRISPR-like structural properties. The system — array-associated reverse transcriptases, or ART — may be programmable in ways biology hasn't seen before. Or it may not. The honest answer is still 'we're checking.'

BuilderResearch

An AI proposed a drug discovery fix. The wet lab ran 10,080 experiments to check. It held.

OpenAI's GPT-5.4 and Molecule.one's Maria AI ran a three-month chemistry collaboration and published the result June 17: AI proposed TEMPO as the fix for a difficult drug synthesis reaction; 10,080 physical wet-lab experiments later, the hypothesis survived. Average yield improved from 16.6% to 25.2%. This is the first publicly documented case of a frontier model driving a real wet-lab chemistry discovery.

← All stories in the archive

Subscribe

A little clarity, once a week.

The week’s AI stories, with context. Free on Monday mornings. Unsubscribe anytime.

🌿